Lupin Rationalizes Japan Operations, Sheds Injectables Business

Lupin sells Japanese injectables business, eight years after it made an acquisition in that segment there. The Indian firm now plans to concentrate on building a hybrid pharma model in the country.

Trees
Lupin Streamlines Japan Operations • Source: Shutterstock

Lupin Ltd. is divesting its injectables business in Japan to the Neopharma group as the Indian firm streamlines its operations there and hones its focus on a “hybrid” (brand/generics) pharma model.

The sell-off comes almost eight years after Lupin snapped up the Tokyo-based specialty injectables firm, I’rom Pharmaceutical Co. (since renamed...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia